VEGFA and breast carcinoma: The serum levels of sST2 and IL-33 in breast cancer patients had significant correlations with VEGF (sST2: r = 0.164, P = 0.045; Figure 1D, IL-33: r = 0.375, P < 0.0001; Figure 1E).